High N-terminal pro-B-type natriuretic peptide: A biomarker of lung cancer?

Clinical Lung Cancer

Volumn 11, Issue 5, 2010, Pages 341-345

  Aujollet, Nathalie ^a   Meyer, Marjorie ^a   Cailliod, Romain ^a   Combier, Fanny ^a   Coignet, Yann ^a   Campard, Sebastien ^a   Facy, Olivier ^a   Bernard, Alain ^a   Girard, Claude ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Atrial fibrillation; Cardiac biomarker; Dysthyroidy; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGE; ARTICLE; BLOOD LEVEL; ELECTIVE SURGERY; FEMALE; GENDER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; RISK FACTOR; SMOKING;

EID: 77957043843     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2010.n.043     Document Type: Article

References (37)

1. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007; 50:2357-2368
2. Andrews N, Jenkins J, Andrews G, et al. Using postoperative cardiac Troponin-I (cTi) levels to detect myocardial ischaemia in patients undergoing vascular surgery. Cardiovasc Surg 2001; 9:254-265
3. Baker M. In biomarkers we trust? Nat Biotechnol 2005; 23:297-304.
4. Sánchez-Moreno C, Dashe JF, Scott T, et al. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004; 35:163-168
5. Januzzi JL, Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95:948-954
6. Logeart D, Saudubray C, Beyne P, et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 2002; 40:1794-1800
7. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167
8. Tung RH, Camargo CA, Jr, Krauser D, et al. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med 2006; 48:66-74.
9. Baggish AL, van Kimmenade RR, Januzzi JL, Jr. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Am J Cardiol 2008; 101:49-55.
10. Mueller C, Breidthardt T, Laule-Kilian K, et al. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007; 137:4-12.
11. Wei T, Zeng C, Chen L, et al. Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide. Int J Clin Pract 2005; 59:891-894
12. Bibbins-Domingo K, Gupta R, Na B, et al. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 2007; 297:169-176
13. Feringa HH, Schouten O, Dunkelgrun M, et al. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart 2007; 93:226-231
14. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies to Open Occluded Arteries (GUSTO)-IV substudy. Circulation 2003; 108:275-281
15. Staub D, Jonas N, Zellweger MJ, et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 2005; 118:1287.
16. Collinson PO, Gaze DC. Cardiac biomarkers in chronic renal disease. Scand J Clin Lab Invest Suppl 2008; 241:104-108
17. Morello A, Lloyd-Jones DM, Chae CU, et al. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2007; 153:90-97
18. Jones AE, Kline JA. Elevated brain natriuretic peptide in septic patients without heart failure. Ann Emerg Med 2003; 42:714-715
19. McLean AS, Huang SJ, Hyams S, et al. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35:1019-1026
20. Bayes-Genis A, DeFilippi C, Januzzi JL, Jr. Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol 2008; 101:89-94.
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
22. Hilbe JM. Logistic Regression Models. Boca Raton, FL: Chapman & Hall/CRC Press, 2009.
23. Harrell FE, Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag, 2001.
24. Hosmer DW, Lemesbow S. A goodness-of-fit test for multiple regression model. Commun Statistics Theo Metho 1980; 9:1043-1069
25. Steyerberg EW, Harrell FE, Jr, Borsboom GJ, et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54:774-781
26. Lafaras C, Mandala E, Saratzis A, et al. Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small-cell lung cancer. Onkologie 2009; 32:389-392
27. de Bold AJ, Borenstein HB, Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28:89-94.
28. Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature 1988; 332:78-81.
29. Sudoh T, Minamino N, Kangawa K, et al. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168:863-870 (Pubitemid 20164622)
30. Schweitz H, Vigne P, Moinier D, et al. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J Biol Chem 1992; 267:13928-13932
31. Wu F, Wu Q. Corin-mediated processing of pro-atrial natriuretic peptide in human small cell lung cancer cells. Cancer Res 2003; 63:8318-8322
32. Heikkilä K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007; 61:824-833
33. Tonstad S, Cowan JL. C-reactive protein as a predictor of disease in smokers and former smokers: a review. Int J Clin Pract 2009; 63:1634-1641
34. Vila G, Resl M, Stelzeneder D, et al. Plasma NT-proBNP increases in response to LPS administration in healthy men. J Appl Physiol 2008; 105:1741-1745
35. Maisel AS, Clopton P, Krishnaswamy P, et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 2004; 147:1078-1084
36. Hildebrandt P, Collinson PO. Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients. Am J Cardiol 2008; 101:25-28
37. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362:316-322